// App-Quantinova.ai

639 : Subtyping of pancreatic cancer patient-derived xenograft tumors and implications for anticancer agent testing

Researchers

Presenter

  • Peter Bronsert

Principal Investigators

  • Tim Kees

  • Bruno Zeitouni

  • Anne-Lise Peille

  • Manuel Landesfeind

  • Heinz-Herbert Fiebig

  • Simon Kuesters

  • Vincent Vuaroqueaux

Medical Centers

  • Institute of Pathology, University Medical Center Freiburg, Freiburg, Germany

  • Novartis AG, Basel, Switzerland

  • Oncotest GmbH, Freiburg, Germany

  • General and Visceral Surgery, University medical center Freiburg, Freiburg, Germany

Locations

  • Germany

  • Switzerland

Companies

  • Oncotest GmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved